NCT01832987View on ClinicalTrials.gov

Pharmacokinetic Parameters of Co-trimoxazole

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Tuberculosis
Interventions
DRUG

co-trimoxazole

On 4, 5 or 6 consecutive days, co-trimoxazole 960 mg will be added to the normal treatment regimen

Trial Locations (1)

Unknown

UMCG - Tuberculosis Center, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT01832987 - Pharmacokinetic Parameters of Co-trimoxazole | Biotech Hunter | Biotech Hunter